Bifeprunox in the Treatment of Schizophrenia

Status:
Completed

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

Study of the long-term efficacy and safety of bifeprunox in the treatment of schizophrenia. Extension to study S154.3.001.

Phase 3

Solvay Pharmaceuticals